Virtu Financial’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $258K | Buy |
+18,438
| New | +$258K | 0.01% | 814 |
|
|
2024
Q1 | – | Sell |
-15,576
| Closed | -$334K | – | 1553 |
|
|
2023
Q4 | $334K | Buy |
+15,576
| New | +$334K | 0.03% | 563 |
|
|
2021
Q1 | – | Sell |
-3,373
| Closed | -$283K | – | 1688 |
|
|
2020
Q4 | $283K | Sell |
3,373
-4,428
| -57% | -$372K | 0.03% | 667 |
|
|
2020
Q3 | $280K | Buy |
+7,801
| New | +$280K | 0.05% | 462 |
|
|
2019
Q4 | – | Sell |
-10,614
| Closed | -$163K | – | 1517 |
|
|
2019
Q3 | $163K | Buy |
+10,614
| New | +$163K | 0.01% | 1010 |
|
|
2018
Q3 | – | Sell |
-12,274
| Closed | -$187K | – | 1653 |
|
|
2018
Q2 | $187K | Buy |
+12,274
| New | +$187K | 0.01% | 1527 |
|